GC Pharma (006280) - Financial and Strategic SWOT Analysis Review

GC Pharma (006280) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the companys businesses and operations. The profile has been compiled by it to bring to you a clear and an unbiased view of the companys key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

- Business description A detailed description of the companys operations and business divisions.
- Corporate strategy Analysts summarization of the companys business strategy.
- SWOT Analysis A detailed analysis of the companys strengths, weakness, opportunities and threats.
- Company history Progression of key events associated with the company.
- Major products and services A list of major products, services and brands of the company.
- Key competitors A list of key competitors to the company.
- Key employees A list of the key executives of the company.
- Executive biographies A brief summary of the executives employment history.
- Key operational heads A list of personnel heading key departments/functions.
- Important locations and subsidiaries A list and contact details of key locations and subsidiaries of the company.
- Key manufacturing facilities A list of key manufacturing facilities of the company.
- Detailed financial ratios for the past five years The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

GC Pharma(GC Pharma) formerly known as Green Cross Corp, a subsidiary of Green Cross Holdings Corp provides plasma protein therapeutics and vaccines. The company develops, manufactures and markets a wide product portfolio comprising plasma derivatives including albumin, immunoglobulin, and antithrombin; vaccines for infectious diseases; prescription drugs for treating cardiovascular, respiratory, central nervous system (CNS), gastrointestinal and immunology diseases, musculoskeletal disorders, genetic disorders, metabolic disorders and hematological disorders; and Over-the-counter (OTC) drugs including anti-inflammatory drugs, anti-allergic products and others. The company focuses its research and development activities at developing pharmaceuticals for difficult to treat diseases, including cancer. GC Pharma is headquartered Yongin-si, Gyeonggi-do, South Korea.

GC Pharma Key Recent Developments

Jul 31,2018: GC Pharma Reports Q2 2018 Results
Jul 03,2018: Platform technologies key to developing new drugs
May 20,2018: GC Pharma to Establish Curevo - a Seattle-based New Company Dedicated to Development of New Vaccines
Apr 27,2018: GC Pharma Announces Q1 2018 Results
Mar 08,2018: GC Pharma gets Korean approval for Lantus biosimilar

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the companys business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The companys core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.



List of Tables 5
List of Figures 5
Section 1 - About the Company 6
GC Pharma - Key Facts 6
GC Pharma - Key Employees 7
GC Pharma - Key Employee Biographies 8
GC Pharma - Major Products and Services 9
GC Pharma - History 10
GC Pharma - Company Statement 16
GC Pharma - Locations And Subsidiaries 17
Head Office 17
Other Locations & Subsidiaries 17
Section 2 Company Analysis 19
Company Overview 19
GC Pharma - Business Description 20
Business Segment: Eliminations 20
Performance 20
Business Segment: Green Cross Corp 20
Overview 20
Performance 20
Business Segment: Green Cross Genome Co Ltd 20
Overview 20
Performance 20
Business Segment: Green Cross LabCell Co Ltd 21
Overview 21
Performance 21
Business Segment: Green Cross Medical Science Co Ltd 21
Overview 21
Performance 21
Business Segment: Green Cross Medis Corp 21
Overview 21
Performance 21
Business Segment: Green Cross Wellbeing Co Ltd 21
Overview 21
Performance 21
Business Segment: Invac Pharm Corp 22
Overview 22
Performance 22
Geographical Segment: Domestic 22
Performance 22
Geographical Segment: Overseas 22
Performance 22
R&D Overview 22
GC Pharma - Corporate Strategy 23
GC Pharma - SWOT Analysis 24
SWOT Analysis - Overview 24
GC Pharma - Strengths 24
GC Pharma - Weaknesses 25
GC Pharma - Opportunities 26
GC Pharma - Threats 27
GC Pharma - Key Competitors 28
Section 3 Company Financial Ratios 29
Financial Ratios - Capital Market Ratios 29
Financial Ratios - Annual Ratios 30
Performance Chart 33
Financial Performance 33
Financial Ratios - Interim Ratios 34
Financial Ratios - Ratio Charts 35
Section 4 Companys Lifesciences Financial Deals and Alliances 36
GC Pharma, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 36
GC Pharma, Pharmaceuticals & Healthcare, Deals By Type, 2012 to YTD 2018 37
GC Pharma, Recent Deals Summary 38
Section 5 Companys Recent Developments 39
Jul 31, 2018: GC Pharma Reports Q2 2018 Results 39
Jul 31, 2018: GC Pharma Reports Q2 2018 Results 40
Jul 31, 2018: GC Pharma Reports Q2 2018 Results 41
May 20, 2018: GC Pharma to Establish Curevo - a Seattle-based New Company Dedicated to Development of New Vaccines 42
Feb 05, 2018: GC Pharma Reports Full Year 2017 Results 43
Apr 29, 2017: Green Cross to Build Cell Therapy Manufacturing Facility in China 44
Section 6 Appendix 45
Methodology 45
Ratio Definitions 45
About GlobalData 49
Contact Us 49
Disclaimer 49

List Of Tables


GC Pharma, Key Facts 6
GC Pharma, Key Employees 7
GC Pharma, Key Employee Biographies 8
GC Pharma, Major Products and Services 9
GC Pharma, History 10
GC Pharma, Other Locations 17
GC Pharma, Subsidiaries 17
GC Pharma, Key Competitors 28
GC Pharma, Ratios based on current share price 29
GC Pharma, Annual Ratios 30
GC Pharma, Annual Ratios (Cont...1) 31
GC Pharma, Annual Ratios (Cont...2) 32
GC Pharma, Interim Ratios 34
GC Pharma, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 36
GC Pharma, Pharmaceuticals & Healthcare, Deals By Type, 2012 to YTD 2018 37
GC Pharma, Recent Deals Summary 38
Currency Codes 45
Capital Market Ratios 45
Equity Ratios 46
Profitability Ratios 46
Cost Ratios 47
Liquidity Ratios 47
Leverage Ratios 48
Efficiency Ratios 48

List Of Figures


GC Pharma, Performance Chart (2013 - 2017) 33
GC Pharma, Ratio Charts 35
GC Pharma, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 36
GC Pharma, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 37

AGC Inc (5201) - Financial and Strategic SWOT Analysis Review

AGC Inc (5201) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the companys businesses and operations. The profile has been compiled by GlobalData

USD 125 View Report

BGC Partners Inc (BGCP) - Financial and Strategic SWOT Analysis Review

BGC Partners Inc (BGCP) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the companys businesses and operations. The profile has been compiled

USD 125 View Report

GC Pharma (006280) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

GC Pharma(GC Pharma) formerly known as Green Cross Corp, a subsidiary of Green Cross Holdings Corp provides plasma protein therapeutics and vaccines. The company develops, manufactures and markets a wide

USD 250 View Report

Fill The Form For Sample Request

Note : * Kindly provide us with your company id and get the sample reports at the earliest.

There is no Reviews available